Your Endothelial Function Supplement Does Not Know What Endothelial Cells Do

The Oasis Health Journal · Submitted September 9, 2026 · 1:31 PM EDT

By Deke Fontaine · Edited by Hal Weinstock

Here is a thing that will make you mad if you have bought an endothelial function supplement in the last five years: the industry skips the part where they test whether the product does anything to the cells that actually run your circulatory system.

I am talking about endothelial cells. They line every blood vessel in your body, from your aorta down to capillaries so narrow a red blood cell has to fold itself in half to get through. They are not decorative. They control whether your vessels dilate or constrict, whether inflammation ramps up or stands down, whether a clot forms or dissolves, whether immune cells get through the wall or stay in the bloodstream. When endothelial cells stop working right, that condition is called endothelial dysfunction, and it predicts cardiovascular events better than your cholesterol number, your blood pressure, or your family history of dying mad at someone over a card game.

And we do not test it.

What The Best Endothelial Function Supplement Actually Needs To Prove

Walk into any supplement aisle and you will see thirty bottles claiming to support heart health, boost nitric oxide production, or improve circulation. Read the back. They will cite studies that measured cholesterol, triglycerides, C-reactive protein, maybe some blood pressure numbers if the trial had a nurse on staff. All downstream effects. None of them the thing that makes the decision.

Endothelial function is the decision maker. Cholesterol is the cousin who shows up after the event, sees the damage, and gets blamed for it anyway because someone needed a simple story.

Here is how we know endothelial dysfunction matters: a 2026 integrative genomics analysis published in Renal Failure, which sounds like a weird place to publish cardiovascular findings until you remember that kidneys are just bags of blood vessels with a filtration side gig, identified shared genetic variants between IgA nephropathy and multiple pan-vascular diseases including coronary artery disease and aortic aneurysm. The variants were not in cholesterol transport genes. They were in genes tied to immune regulation, and they were enriched in endothelial cells, macrophages, spleen, lung, and blood. The authors prioritized candidate genes using multi-omics tools, which is a fancy way of saying they checked whether the genes were actually turned on in the relevant tissue, and what they found pointed straight at the endothelial lining as a shared site of pathology across cardiovascular conditions.

So if you are making a nitric oxide booster supplement and claiming it supports cardiovascular health, the scientifically honest thing to do is measure endothelial function directly. Use flow-mediated dilation, which is an ultrasound test where they squeeze your arm until the blood stops, then let go and watch how fast the artery opens back up. Or measure circulating endothelial microparticles, which are little chunks of dead endothelial cells that float around in your blood when the lining is falling apart. Or check nitric oxide metabolites in the blood, since nitric oxide is the main signaling molecule endothelial cells use to tell smooth muscle to relax.

You know what the industry does instead? They measure lipids and call it vascular support.

How To Support Healthy Blood Flow Naturally, If We Actually Cared

I realize I am yelling about cell biology like it personally wronged me at a potluck, so let me back up and explain why this makes me so mad.

Endothelial dysfunction happens early. Years before a heart attack. It is detectable, it is measurable, and it responds to intervention. A functioning endothelium produces nitric oxide in response to shear stress, which is the fancy term for blood rubbing against the vessel wall as it flows. That nitric oxide diffuses into the smooth muscle layer underneath and tells it to relax, which opens the vessel, which improves blood flow, which reduces the work your heart has to do. When endothelial cells are damaged by inflammation, oxidative stress, high glucose, or just age and bad luck, they stop making enough nitric oxide. The vessels stay constricted. Blood pressure climbs. Clotting factors get activated. Immune cells start sticking to the wall like they are casing the joint.

That is the moment to intervene.

Right there. Before the plaque, before the clot, before the event that puts you in an emergency room arguing with someone about whether your left arm hurts or you just slept on it wrong.

And what we are doing instead is waiting until cholesterol is high, then selling supplements that lower cholesterol, and then claiming we supported vascular health. We skipped the part where the vessel was making the decision about whether to let cholesterol through the wall in the first place.

What Supplements Improve Endothelial Function, According To Nobody

The same 2026 genomics paper ran a drug repurposing analysis to see what existing medications might be useful in IgA nephropathy patients with cardiovascular risk, and they identified immunosuppressants, lipid-lowering agents, and aspirin as candidates based on gene-drug matching scores. Those are drugs. They have been through trials. They have known mechanisms. And even those authors were careful to say the findings offer opportunities for precision medicine, not that you should start taking cyclosporine because a genomics paper said your kidneys and your heart share some variants.

Now compare that caution to the average label on a heart health supplement stack. No mechanistic data. No endothelial function testing. Just a vague claim about circulation and a photo of someone jogging at sunrise like that proves anything.

I am not saying supplements cannot affect endothelial function. Some probably do. L-arginine is a nitric oxide precursor. Citrulline gets converted to arginine. Omega-3 fatty acids reduce endothelial inflammation in some trials. Polyphenols from grapes or berries or cocoa might improve nitric oxide bioavailability, though the effect size is all over the map depending on who funded the study and whether they remembered to control for the participants eating actual food during the trial period.

What I am saying is: if you are going to put the words 'supports vascular health' on a bottle and charge me $40 for it, test the vasculature. Not the lipid panel. Not the inflammatory marker that correlates with everything and predicts nothing. The actual endothelial cells that decide whether my arteries work.

Supplements That Boost Nitric Oxide Production, Maybe, We Think, Hard To Say

The problem is not that endothelial function is unmeasurable. It is measurable. The problem is that measuring it is inconvenient and expensive, and the supplement industry has decided that inconvenient and expensive is the same as impossible, so they measure cholesterol instead and hope you do not notice the bait-and-switch.

A 2026 review on chronic limb-threatening ischemia, which is what happens when your leg arteries are so clogged you are looking at amputation, spent thirty pages talking about host-state biomarkers that predict outcomes in patients getting cell therapy. Inflammatory markers, metabolic markers, renal function, perfusion indices, all kinds of variables that shape what the authors called 'the regenerative microenvironment.' And even in that population, where the vessels are so bad that revascularization is not an option and people are trying experimental stem cell injections as a Hail Mary, the authors were careful to say these are hypothesis-generating candidate variables for prospective testing, not validated predictive biomarkers.

Hypothesis-generating. That means: we think this might matter, we have some evidence it correlates with outcomes, but we have not proven causation and we are not telling you to make treatment decisions based on it yet.

That is a trial in people whose arteries are so bad they might lose a leg. Now go read the back of a nitric oxide supplement marketed to healthy adults who want to 'optimize their cardiovascular system,' and tell me which one sounds more scientifically honest.

Vascular Support Supplements For Active People Who Deserve Actual Data

I am not mad at the supplement. I am mad at the gap between the claim and the evidence. If a product says it improves blood flow, and blood flow is controlled by endothelial cells, and the study cited on the label measured cholesterol, then someone in that supply chain decided to lie by omission and hope nobody noticed.

And look, I get it. Testing endothelial function requires an ultrasound machine, a trained sonographer, and about fifteen minutes per participant. You cannot do that in a twelve-week trial with two hundred people and a bottle of capsules unless you have the kind of budget that makes investors nervous. It is easier to draw blood, send it to a lab, get back a lipid panel, and call that cardiovascular support.

But easier is not the same as correct, and calling it vascular support when you only measured the stuff that is easy to measure is how we end up with an entire industry of products that might work, probably do not, and definitely have not been tested for the thing they claim to do.

Your endothelial cells are not a cholesterol storage problem. They are a live cell dysfunction problem, they predict cardiovascular events better than the numbers we actually measure, and we are selling solutions to the wrong part of the system because the right part is expensive to test.

That is not science. That is marketing with a lab coat on.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review, Regenerative therapy (2026).
2. The gut-lung axis and viral pneumonia: Unrevealing the gut microbiota, Pharmaceutical science advances (2026).
3. Shared genetics of IgA nephropathy and cardiometabolic diseases revealed by integrative genomic analysis, Renal failure (2026).
4. miR-181a-5p: a key regulator of placental function in health and disease, RNA biology (2026).